KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBIT Margin (2016 - 2025)

Teladoc Health's EBIT Margin history spans 12 years, with the latest figure at 5.6% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 192.0% year-over-year to 5.6%; the TTM value through Dec 2025 reached 10.39%, up 2934.0%, while the annual FY2025 figure was 10.39%, 2934.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 5.6% at Teladoc Health, up from 8.29% in the prior quarter.
  • Across five years, EBIT Margin topped out at 5.31% in Q4 2023 and bottomed at 1179.69% in Q1 2022.
  • The 5-year median for EBIT Margin is 11.67% (2021), against an average of 130.24%.
  • The largest annual shift saw EBIT Margin tumbled -116103bps in 2022 before it soared 116744bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 7.47% in 2021, then plummeted by -7904bps to 598.32% in 2022, then skyrocketed by 99bps to 5.31% in 2023, then plummeted by -42bps to 7.53% in 2024, then increased by 26bps to 5.6% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's EBIT Margin are 5.6% (Q4 2025), 8.29% (Q3 2025), and 8.61% (Q2 2025).